Japan's ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research

Japan-based startup ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis...

January 29, 2025 | Wednesday | News
AB2 Bio signs licensing agreement worth $500 M with Nippon Shinyaku for ultra-rare autoimmune disease treatment

AB2 Bio, a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory ...

January 28, 2025 | Tuesday | News
AstraZeneca and Daiichi Sankyo's Datroway Approved in US, Cuts Cancer Progression Risk by 37%

First approval in the US for AstraZeneca and Daiichi Sankyo’s Datroway based on TROPION-Breast01 results showi...

January 27, 2025 | Monday | News
Renascience to open branch lab of Northwestern University Longevity Institute in Japan

Japanese firm Renascience has concluded a joint research agreement on ageing with Prof. Douglas E. Vaughan, Direct...

January 24, 2025 | Friday | News
Japan's Daiichi Sankyo establishes Smart research lab in US to expedite drug discovery

Japanese pharmaceutical firm Daiichi Sankyo has established a state-of-the-art research laboratory in San Diego, Ca...

January 23, 2025 | Thursday | News
Sumitomo to market Johnson & Johnson's schizophrenia drug in Japan

Sumitomo Pharma has concluded a co-promotion collaboration partner agreement with Johnson & Johnson (J&J) in Jap...

January 21, 2025 | Tuesday | News
Shimadzu releases world's first gas chromatograph systems with CO2 reduction visualisation function

Japan headquartered Shimadzu Corporation has released seven new Brevis GC-2050 Systems for the Green Transform...

January 20, 2025 | Monday | News
Germany's BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy

BioMed X, an independent biomedical research institute based in Heidelberg, Germany, has announced the launch of a new c...

January 16, 2025 | Thursday | News
Taiwan's Advanced Genomics and Cancer Precision Medicine partner to launch bladder cancer screening test in Japan

Taiwan-based Advanced Genomics APAC Co. has announced the signing of an exclusive service provider agreement with Cancer...

January 15, 2025 | Wednesday | News
Japan's NEC and Biomy to expand AI-based analytical platforms in digital pathology

Japan-based NEC Corporation and Biomy, Inc. have signed a Memorandum of Understanding (MoU) for a joint market...

January 10, 2025 | Friday | News
Japan's Kaneka Corporation acquires 96.8% of shares of Israeli medical equipment company EndoStream

Japanese firm Kaneka Corporation has acquired 96.8% of shares of EndoStream Medical, an Israeli medical equipment compan...

January 9, 2025 | Thursday | News
Japan's Kaken Pharma enters into license agreement for STAT6 inhibitor with Johnson & Johnson for $1.2 B

Japan-based Kaken Pharmaceutical Co. has entered into a license agreement with Johnson & Johnson for the globa...

January 7, 2025 | Tuesday | News
Japanese firms JCR Pharmaceuticals and Modalis Therapeutics move forward with development of novel gene therapy

JCR Pharmaceuticals Co. and Modalis Therapeutics Corporation have validated the initial proof of concept ...

January 6, 2025 | Monday | News
Japan approves first and only facilitated subcutaneous immunoglobulin for Agammaglobulinemia and Hypogammaglobulinemia

Takeda has announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA [Immun...

January 5, 2025 | Sunday | News
Japan's Fujirebio and Eisai to establish diagnostic technologies for various neurodegenerative diseases

Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a...

December 24, 2024 | Tuesday | News
Japan's Sumitomo to establish regenerative medicine and cell therapy joint venture

Japan's Sumitomo Chemical Co. and Sumitomo Pharma have studied restructuring measures to accelerate the development of r...

December 20, 2024 | Friday | News
Takeda, Tohoku University form alliance to strengthen drug discovery capabilities in Japan

Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...

December 18, 2024 | Wednesday | News
Japan's Shimadzu develops platform to support gene therapy manufacturing

Japan-based Shimadzu Corporation has signed an investment contract with U-Medico Inc, a contract research organisation (...

December 17, 2024 | Tuesday | News